Provided by Tiger Trade Technology Pte. Ltd.

Lyra Therapeutics, Inc.

0.6600
0.0000
Volume:5.60K
Turnover:3.69K
Market Cap:1.17M
PE:-0.03
High:0.6600
Open:0.6600
Low:0.6600
Close:0.6600
52wk High:37.50
52wk Low:0.3100
Shares:1.77M
Float Shares:1.32M
Volume Ratio:0.53
T/O Rate:0.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-22.9324
EPS(LYR):-71.7474
ROE:-6594.98%
ROA:-36.06%
PB:-0.11
PE(LYR):-0.01

Loading ...

Lyra Therapeutics FY25 net loss narrows to $29 million; revenue slips to $0.4 million

Reuters
·
Apr 01

BRIEF-Lyra Therapeutics Inc Withdraws Appeal Of Nasdaq Delisting Determination - SEC Filing

Reuters
·
Mar 17

Lyra Therapeutics Withdraws Nasdaq Appeal, Faces Imminent Delisting

TIPRANKS
·
Mar 17

Lyra Therapeutics Inc - Trading in Lyra Therapeutics Stock to Be Suspended at Open on March 17, 2026 - SEC Filing

THOMSON REUTERS
·
Mar 17

Nasdaq to suspend Lyra Therapeutics shares on March 17 after delisting appeal withdrawal

Reuters
·
Mar 17

BUZZ-U.S. STOCKS ON THE MOVE-Customers Bancorp, Forgent Power Solutions, Nvidia

Reuters
·
Mar 17

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:17 PM

Reuters
·
Mar 17

Lyra Therapeutics Inc expected to post a loss of $7.14 a share - Earnings Preview

Reuters
·
Mar 09

Lyra Therapeutics Faces Nasdaq Delisting After Becoming Shell

TIPRANKS
·
Feb 07

Lyra Therapeutics common stock to be delisted by Nasdaq

TIPRANKS
·
Feb 07

Nasdaq Moves to Delist Lyra Therapeutics Over Public Shell Status and Equity Shortfall

Reuters
·
Feb 07

Top Midday Decliners

MT Newswires Live
·
Jan 13

Gold Rises Sharply; Lyra Therapeutics Shares Plunge

Benzinga_recent_news
·
Jan 13

BUZZ-U.S. STOCKS ON THE MOVE-AbCellera Biologics, Zymeworks, Silver miners

Reuters
·
Jan 12

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:24 AM

Reuters
·
Jan 12

BUZZ-Lyra Therapeutics plunges after halting development of lead nasal drug

Reuters
·
Jan 12

BRIEF-Lyra Therapeutics Inc - Terminates CEO Maria Palasis And CFO Jason Cavalier - SEC Filing

Reuters
·
Jan 12

Lyra Therapeutics Suspends LYR-210 Development and Reduces Workforce

Reuters
·
Jan 12

Lyra Therapeutics Provides Corporate Update

THOMSON REUTERS
·
Jan 12

Lyra Therapeutics Inc: Expects Lyra's Cash Runway to Last Into Q3 of 2026

THOMSON REUTERS
·
Jan 12